Yarrow Bioscience Inc
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $4.6M | $674.0K |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $29.0M | $11.3M |
| SG&A Expense | $5.2M | $3.8M |
| Operating Income | $-29.6M | $-14.3M |
| Operating Margin | -645.9% | -2,126.4% |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | $0 | — |
| Net Income | $-29.1M | $-14.1M |
| Net Margin | -634.6% | -2,087.2% |
| EPS (Basic) | $-0.47 | $-0.24 |
| EPS (Diluted) | $-0.47 | $-0.24 |
| Shares Outstanding (Basic) | 63.6M | 63.4M |
| Shares Outstanding (Diluted) | 63.6M | 63.4M |
| Dividends Per Share | — | — |